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This internship report on the subject "Modelling interactions between tumour cells and sup-
porting adipocytes in breast cancer", is a summary of the work accomplished during 6 months
of internship at the Laboratoire Jacques-Louis-Lions (LJLL). Since this internship is intended
to be followed by a PhD on the same subject, most of the work was bibliographical and aimed
at understanding the biological background, the modelling and analysis of phenotypically struc-
tured populations, as well as the envisaged experiments, that are performed at the Laboratoire
de Biologie et Thérapeutique des Cancers (LBTC) in Michèle Sabbah’s team. Those experi-
ments will allow for validation and parametrization of the models. An other part of the work
was to start proving new mathematical results, and perform numerical simulations to investigate
different scenarios.
Introduction
In breast cancer, invasion of the micro-environment implies potential bidirectional communica-
tion between cancer cells and the adipose tissue. Biological evidence suggests that adipocytes,
in particular, are key-actors in tumorigenesis and invasion: they both enhance proliferation of
the cancer cells and favor acquisition of a more invasive phenotype. To understand these effects,
mathematical modelling (thanks to tools developed in theoretical ecology) is used to perform
asymptotic analysis in number of cells and distribution of phenotypes. These models can be
tuned through confrontation with experimental data coming from co-cultures of cancer cells
with adipocytes.
The first part of this report is devoted to presenting the biological background on breast cancer
and its environment. We then present the main aspects of the mathematical modelling, and
how it is expected to be validated experimentally. In the third part, we summarize and prove
many important results that have been obtained on a single integro-differential equation rep-
resenting the evolution of a population of individuals structured with a phenotypic trait. The
next part consists of a first glance at possible generalizations of those results to a system of
integro-differential equations coupled mutualistically. In a fifth and last part, we introduce how
we intend to parametrize the models through explicit computations and numerical simulations.
3
1 Breast cancer and its environment
1.1 Breast cancer : a brief overview
1.1.1 Some statistics in France
What follows is a summary from a survey issued by the IVS (Institut de Veille Sanitaire). The
statistics are taken from the year 2012, exclusively in France. Note that the incidence and
mortality figures have been roughly stable for the last decade.
In France, in 2012, around 50, 000 new cases were reported, for around 10, 000 deaths. One
woman out of eight will have breast cancer at some time in life. After 5 years, the survival rate
is about 86% (all types included). Age is a strong factor, as 45% of breast cancers are diagnosed
between 50 and 69 years and around 33% after 69 years.
1.1.2 Location of breast cancers
Breast cancer is a malignant tumor, whose primary site is the mammary gland (i.e. the breast).
A breast consists of 15 to 20 lobes, themselves composed of many lobules. The lobes are sur-
rounded by the adipose tissue, which separates them from the skin. The lobules’ function is to
produce the milk, which is brought to the nipple by the milk ducts. Fig. 1 below provides a
schematic representation of the mammary gland.
Figure 1: Cross-section scheme of the mammary gland (Wikipedia)
Breast cancers are first classified based on whether the tumour has invaded its local micro-
environment or not:
• most cancers start either in the lobules or in the ducts, and as long as healthy cells are
not invaded, the cancer is said to be in situ;
• if the cancer invades the adipose tissue, however, it is said to be an invasive cancer.
Around 90% of deaths due to breast cancer occur because of migration of cancers cells to
other organs. The first metastases are often found in the lymph nodes of the armpit (the axillary
lymph nodes). The breast cancer essentially metastasizes to the bone, lungs, regional lymph
nodes, liver and brain (with bones representing the most common site).
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1.1.3 Different types of breast cancers
Depending on the involved cancer cells’ phenotype, two breast cancers can differ drastically, and
this has very important implications in terms of therapeutical strategies and life expectancy. To
cover the most prevalent types, it is enough to characterize a cancer cell based on the presence
(+) of absence (−) of:
• hormone receptors for estrogens (ER) and progesterone (PR);
• the gene HER2, responsible for over-expression of the growth-promoting protein HER2.
From that, it is possible to distinguish 3 types of breast cancers:
• Luminal A (ER+, PR+, HER2-) and B (ER+, PR-, HER2+) → 70%;
• HER2 positive (ER-, PR- , HER2+) → 15%;
• "triple-negative" or "basal-like" (ER-, PR-, HER2-) → 15%,
where the percentages indicate the approximate contribution of each type to the total number
of breast cancers in France (data taken from the Curie Institute website).
1.1.4 Therapeutics for breast cancer
As for other cancers, clinical treatment of breast cancers consists of several approaches than can
be combined. The choice of one or several therapies, as well as their scheduling and duration,
depends on a wide variety of factors, including which the type of cancer, its location (invasive or
not, metastases), the size of the different tumors and, of course, the health status of the patient.
One can identify 5 main approaches for a clinician facing a breast cancer:
• chemotherapy
Chemotherapy refers to chemical drugs that kill the cancer cells (cytotoxic effect) and/or block
their proliferation (cytostatic effect). These are often very toxic drugs, which can also affect
healthy cells.
• surgery
Cancer surgery is the removal of (part of) the tumor and its surrounding tissues.
• radiotherapy
Radiotherapy uses high-energy rays to target the cancer cells.
• antiangiogenic drugs
When a tumor grows, the cells at the center cannot access nutrients anymore and become qui-
escent (they stop dividing, waiting for better conditions). In those conditions, cancer cells are
able to create their own vasculature, ensuring access to nutrients and potential migration. This
is called angiogenesis, a process specifically targeted by antiangiogenic drugs.
• blocking interactions between the tumor and its environment
Although the immune system can fight cancer, cancer cells also use their environment to their
advantage, so as to create better conditions for their survival and proliferation. In breast cancer,
there are indeed mutualistic interactions between cancer cells and cells of the adipose tissue (see
next section).
1.2 Interactions between the tumour and the adipose tissue
1.2.1 Short description of the adipose tissue
The main role of adipose tissue is to serve as an energy depot. There are few main types of cells
in the adipose tissue, listed thereafter:
• adipocytes
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Adipocytes are round cells, the most represented cells of the adipose tissue. They confer it its
function, as adipocytes maintain an energy balance by storing excess fat and releasing it when
needed in the form of fatty acids. They can also synthesize estrogens [12].
• fibroblasts
Fibroblasts are more elliptical cells. They synthesize many proteins than can be found in the
extra-cellular matrix (ECM), thus contributing to structuring the stroma and having a wound-
healing function.
• endothelial cells
Endothelial cells form a thin layer around the blood vessels.
• macrophages
Macrophages are cells that engulf and digest (this is called phagocytosis) anything that does
not have the types of proteins specific to the surface of healthy body cells on its surface.
• preadipocytes
Preadipocytes are undifferentiated fibroblasts that can be stimulated to form adipocytes.
1.2.2 Mutualistic interactions
Epidemiological studies have shown a positive link between obesity and breast cancer, both in
terms of risk of developing the disease and poor prognosis once it has been diagnosed [2, 9], at
least for post-menopausal women. For pre-menopausal women, the latter also seems to hold
true, while the former doesn’t: many studies find an negative association between obesity and
risk of developing the disease before menopause [9]. More precisely, obesity is linked to higher
likelihood of larger tumours, recurrence of the disease, and death.
Those studies often use the BMI (body mass index) to define obesity, an index built as a measure
of body fat. Thus, they provide strong evidence of existence of interactions between the tumour
and the adipose tissue.
Furthermore, those conclusions also have biological support. First, obesity is associated with
(subclinical) inflammation of the adipose tissue, a state of the micro-environment which has been
proven to favor cancer progression [13]. Secondly, obesity leads to over-expression of aromatase,
and subsequently, the hormon it synthesizes: estrogen [14]. Estrogens increase proliferation of
ER positive cancer cells. It is also noteworthy that most post-menopausal breast cancers are
ER positive.
Knowledge of such interactions already has applications in clinics: hormone therapy (drugs
that compete with estrogens for binding to estrogen receptors) and aromatase inhibitors are
used. Nonsteroidal anti-inflammatory drugs are also used.
1.3 The key role of adipocytes
Among cells of the adipose tissue, recent biological evidence suggests that adipocytes play a
key role in cell proliferation, invasive phenotype and resistance to therapy as far as cancer cells
are concerned. Adipocytes at the interface with the tumour exhibit a modified phenotype, and
are now called Cancer-Associated Adipocytes (CAAs) [5,15]. They are indeed characterized by
a much smaller size (see Fig. 2) due to delipidation and a lower expression of adiponectin (a
cytokine emitted by mature adipocytes).
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Figure 2: Histology of the invasive front of a human breast carcinoma. Data reproduced
from [15]. In white: adipocytes, in purple: tumour.
1.3.1 In cell proliferation
When cultured in a medium containing soluble factors emitted by adipocytes, cancer cells are
significantly more proliferative, a conclusion that does not hold if the factors are emitted by
fibroblasts [7]. Similar conclusions are obtained in terms of cell proliferation in the case of
cancer cells cultured with adipocytes in a three-dimensional collagen gel matrix [10].
1.3.2 In invasive phenotype
Epithelial to mesenchymal transition (EMT) is a reversible process by which epithelial cells
partly lose their adherent properties (and their polarity), and thus become more motile. This
transition is known to occur in cancer cells, and is strongly related to invasive properties of the
cancer, and metastases. Put in contact with adipocytes through soluble factors only, cancer cells
undergo the EMT [5], proving that adipocytes are linked to cancer invasion. Together with the
change of adipocytes from mature adipocytes (A) to CAAs, this shows that crosstalk between
both populations change their phenotype, a situation summarized in Fig. 3.
Figure 3: Bidirectional communication between adipocytes and cancer cells induce a
change of phenotypes in both populations. E: epithelial, M: mesenchymal, A: (mature) adipocytes,
CAA: cancer-associated adipocytes.
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1.3.3 In resistance to therapy
Different biological studies have shown that, under the influence of adipocytes, cancer cells can
develop a resistance to different therapies.
In [1] the authors show that cancer cells co-cultured with adipocytes have become resistant
to radiotherapy. This effect is independent of whether cancer cells are left in co-culture with
adipocytes, or not (at least on a window of 2 days).
In [6], cancer cells expressing HER2 (HER2+) are found to develop resistance to trastuzumab-
mediated cytotoxicity (trastuzumab is a drug that blocks the extra-cellular part of the receptor
for HER2) if co-cultured with adipocytes or preadipocytes.
8
2 Experimental setting and mathematical modelling
To further study the interactions between cancer cells and adipocytes, the goal is to perform
experiments of co-culture of cancer cells with adipocytes. Mathematical modelling can then
serve as an in silico laboratory to guide experiments and investigate scenarios that are not
directly accessible, or too costly.
2.1 Experimental setting
2.1.1 Principle and cell lines
Given two populations of cells, of cancer cells and adipocytes, they can be grown in direct contact
in a same Petri dish, or separately in two separate chambers. In the last case, interactions
are allowed only by soluble factors (thus not considering possible the effect of direct physical
contact). This is done experimentally thanks to a Transwell co-culture system, whose principle
is presented in Fig. 4.
Figure 4: Principle of a co-culture with a Transwell system
The cell lines that will be used for the experiments are the following :
• Mature adipocytes (obtained by differentiating 3T3-F442A murine preadipocytes)
• Epithelial cancer cells MCF7 (human)
• Mesenchymal cancer cells MCF7-sh-WISP2 (human)
Cultures will be performed in a complete growth medium, and all possible combinations
(including adipocytes and cancer cells alone) will be considered. Every culture will last for 72
hours.
2.1.2 Estimating cell proliferation and distribution in phenotypes
The number of viable cells will be estimated by cell count, using trypan blue exclusion (trypan
blue colors dead cells) every 24 hours.
To quantify the phenotype distribution of the adipocytes, two methods are possible (and can be
combined).
• Estimating the level of expression of adiponectin;
• Estimating the size of the adipocytes.
To quantify the distribution of cancer cells in phenotype, three methods are possible (and
can be combined).
• Estimating the level of expression of E-cadherin;
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• Estimating the adhesion properties of the cancer cells:
these properties will be investigated through dispase disaggregation assay (DDA) following
the protocol schematized in Fig. 5. Loosely speaking, independent monolayers of cancer
cells will be grown until confluency. Cell monolayers will be detached from the culture
dishes through incubation with a proper metalloproteinase dispase. Released monolayers
will be disrupted by standardized pipetting, and a count of floating cell clusters will be
performed. A higher number of floating clusters (i.e., a higher cell dissociation percentage)
will indicate a lower cell-cell adhesion strength.
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Figure 5: Assessing the adhesion properties of the cancer cells
• Estimating the invasion properties of the cancer cells:
a gelatin-invadopodia-assay will be used to measure cell-associated degradation of the
extracellular matrix. In brief, for each culture, cancer cells will be grown on a layer of
green-fluorescein-labeled gelatin. Cell cultures will be stained with rhodamine phalloidin
for actin rich invadopodia puncta (red). Visual inspection and image segmentation will
be used to estimate the degree of degradation of the gelatin, and the concentration of
invadopodia (see Fig. 6);
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Figure 6: Assessing the invasion properties of the cancer cells
2.2 Mathematical modelling
2.2.1 Underlying principles
When one tries to model in vivo tumours, space is an important variable since the increasing
number of cells leads to an increasing pressure and, consequently, to a less favourable environ-
ment for cells. In an experimental setting, however, similar pressure conditions are not observed.
Also, we specifically wish to understand how the interaction between cancer cells and adipocytes
leads to the selection of cancer cells that are more prone to migration, and to the selection of
CAAs. To model the experiments, phenotype is thus a natural structuring variable, at least
more relevant than space.
Consequently, for a given population of cells, we are interested in n(t, x), which represents the
density of cells at time t, of phenotype x. Here, x denotes a given trait or phenotype, which
is considered to be particularly relevant to describe the biological variability within the celle
population. Ideally, this variable must be experimentally identifiable. A typical example is the
concentration of a protein, and x is thus considered to be a continuous variable (lying in some
subset of Rd).
Cells also compete for resources, so that the environment exerts a selective pressure, forcing
the cells to adapt. A second feature is that a cell with a given phenotype might change its
own phenotype and/or give birth to cells with a different phenotype (because of mutations
and epimutations, see below for a definition). This situation suggests that modelling tools
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provided by mathematical ecology (and more particularly, adaptive dynamics) can be used. This
branch of mathematical biology focuses on understanding mathematically how selection occurs
in a population of individuals interacting between themselves and with their environment (in a
competitive and/or mutualistic way), and subject to mutations and epimutations [4, 8, 11].
2.2.2 Typical equation
Let us now introduce a prototype equation (coming from adaptive dynamics) describing the
evolution of a population of cells defined by n(t, x). Close models can for example be found
in [3, 8, 11]. For simplicity, we will assume that the trait lies in some sub-interval of R, say
X := [0 , 1]. The equation for n is given by:
∂n
∂t
(t, x) +
∂
∂x
(v(x)n(t, x)) = β
∂2n
∂x2
(t, x) +R (x, ρ(t))n(t, x). (1)
with initial condition n0 ≥ 0 in L1(X) ∩ L∞(X) and Neumann boundary conditions. We also
assume that the adaptation velocity v vanishes at the boundary.
Each term models a different phenomenon:
• The R (x, ρ(t))n(t, x) term.
R is a fitness function for the cells of phenotype x in the environment created by the
total population (which is modelled by the dependence in the total population given by
ρ(t) :=
∫
X n(t, x) dx). The most common example is
R (x, ρ(t)) = r(x)− d(x)ρ(t) (2)
which amounts to saying that cells give birth at rate r(x) and die at rate d(x)ρ(t). The
dependence in ρ is of logistic type, representing the idea that cells die faster when the total
population is bigger, because of competition for nutrients and space.
• The β ∂
2n
∂x2
(t, x) term
The Laplacian models random epimutations, i.e. random heritable gene expressions that
leaves the DNA unaffected. β quantifies the rate of epimutations. Note that we do not
take mutations into account (usually modelled with a probability kernel) because they are
supposed to occur much less frequently. They are thus here neglected.
Such a term can be called of Darwin-type, since it implies that the emergence or selection
of fitter individuals occurs because of random events.
• The ∂
∂x
(v(x)n(t, x)) term
This advection term means that the density is transported with velocity v(x). It models
non-random epimutations.
Such a term can be called of Lamarck-type, since it implies that the emergence or selection
of fitter individuals occurs because these individuals actively change their phenotype to
adapt to their environment.
2.2.3 Equation for the interaction between adipocytes and cancer cells
To model the experiments of co-culture between cancer cells and adipocytes, we are interested in
the behaviour of the two population densities nC(t, x) (cancer cells) and nA(t, y) (adipocytes).
x and y stand for traits that characterize the phenotype of the individuals:
• for cancer cells, x ranges from 0 for an epithelial phenotype E to 1 for a mesenchymal
phenotype M. x can be linked to the concentration of a protein through a proper normal-
ization;
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• for adipocytes, y ranges from 0 for mature adipocytes A to 1 for cancer-associated adipocytes
CAA. y can be linked to the concentration of a protein through a proper normalization.
Figure 7: Meaning of the traits x and y.
We consider the following set of PDEs
∂nC
∂t
(t, x) +
∂
∂x
(vC (x, ϕA(t))nC(t, x))
= βC
∂2nC
∂x2
+ [RC (x, ρC(t)) +RCA (x, ϕA(t))]nC(t, x)
∂nA
∂t
(t, y) +
∂
∂y
(vA (y, ϕC(t))nA(t, y))
= βA
∂2nA
∂y2
+ [RA (y, ρA(t)) +RAC (y, ϕC(t))]nA(t, y)
(3)
with initial conditions depending on the experiment and Neumann boundary conditions.
The interaction is modelled through dependence of different terms on functions ϕA and ϕC ,
which aim at representing the chemical signal from adipocytes to cancer cells (resp. from cancer
cells to adipocytes). A possible definition is{
ϕC(t) =
∫ 1
0 ψC(x)nC(t, x) dx
ϕA(t) =
∫ 1
0 ψA(y)nA(t, y) dy
(4)
with ψC , ψA increasing functions (modelling the fact that mesenchymal cells or CAAs
are expected to emit more chemical messengers than, respectively, epithelial cells and mature
adipocytes).
The interactions impact two terms:
• The RCA (x, ϕA(t))nC(t, x) and RAC (y, ϕC(t))nA(t, y) terms.
Since the interaction is mutualistic in terms of cell proliferation (at least for cancer cells),
we assume that RCA (x, ϕA) ≥ 0 with equality if and only if ϕA = 0 and, possibly,
RAC (y, ϕC) ≥ 0 with equality if and only if ϕC = 0. Typically, we will take
RCA (x, ϕA) = sC(x)ϕA (5)
with sC(x) ≥ 0 the sensitivity of cancer cells to the chemical messengers. Note that the
population of adipocytes can be seen as inducing an added birth rate for the cancer cells.
• The ∂
∂x
(vC (x, ϕA(t))nC(t, x)) and
∂
∂y
(vA (y, ϕC(t))nA(t, y)) terms
We still assume that vC and vA vanish at the boundary (independently of the value of ϕA
and ϕC respectively) for well-posedness.
Since cancer cells tend to naturally undergo the epithelial to mesenchymal transition, we
assume vC ≥ 0. Since the interaction tends to lead to a change of phenotype from E to
M and A to CAA, we also assume that vC and vA are increasing functions of ϕA and ϕC ,
respectively.
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3 Single integro-differential equation
We now turn our attention to studying mathematically the system of PDEs introduced in the
mathematical modelling, in a simplified way: we assume there is no advection nor diffusion.
Canonical equation and goals
Before studying the system of equations, let us consider the case of a single equation, i.e. one
population only. The case is now well understood [11]. The individuals are defined by a trait or
phenotype x (lying in a given compact set, say X ⊂ Rd), on which their birth and death rate
depend. A simple model is thus:
∂n
∂t (t, x) = [r(x)− d(x)ρ(t)] n(t, x), x ∈ X, t > 0
n(0, x) = n0(x), x ∈ X
(6)
where ρ(t) stands for the total population, that is ρ(t) =
∫
X n(t, x) dx.
There are several main questions that have been addressed, including which:
• What are the dynamics of the total mass ?
• Are there traits selected, and if yes, which ones ?
A canonical and more general setting containing (6) is the following:
∂n
∂t (t, x) = R (x, ρ(t)) n(t, x), x ∈ X, t > 0
n(0, x) = n0(x), x ∈ X
(7)
R can be seen as the fitness of the individuals of trait x in the environment created by the
total population ρ(t). This is the equation that will thereafter be studied, bearing in mind the
simpler case (6).
3.1 Existence and uniqueness
We first provide a priori bounds for ρ, before making sure there exists a unique non-negative
solution with regularity C
(
R+, L1(X)
)
. For that, we make some general and reasonable as-
sumptions on the parameters and initial conditions, i.e.:{
R ∈ C1 (Rd × R)
n0 ≥ 0 ∈ L1(X) (8)
and we assume that there exist positive constants ρm, ρM , d such that
∀x ∈ X, R(x, ρm) ≥ 0 and ∃xm ∈ X, R(xm, ρm) = 0
∀x ∈ X, R(x, ρM ) ≤ 0 and ∃xM ∈ X, R(xM , ρM ) = 0
∂R
∂ρ ≤ −d
(9)
The two first assumptions mean that ρm and ρM are (global) minimal and maximal capacities:
if ρ is below ρm, the density of individuals of any trait increases. Similarly, if ρ is above ρM ,
the density decreases for any trait. Furthermore, the existence of xm and xM imply that they
are the best constants to achieve this. The last statement models the idea that an increase in ρ
results in greater competition. In view of (6), d can be seen as a minimal death rate.
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3.1.1 A priori bounds
Lemma 3.1. Suppose we have a solution of (7) in C
(
R+, L1(X)
)
, with the initial data such
that ρm ≤ ρ0 := ∫X n0(x) dx ≤ ρM .
Then, for all t > 0:
ρm ≤ ρ(t) ≤ ρM .
Proof. Integrating the equation yields, for all t ≥ 0:
dρ
dt
(t, x) ≤
[
max
x∈X
R (x, ρ(t))
]
ρ(t)
Let  > 0. If ρ(t) is close to ρM + , its derivative becomes negative and this is enough to ensure
ρ(t) ≤ ρM +  for all t > 0. We then let  go to 0 to get the upper bound.
The same arguments provide the other inequality.
3.1.2 Proof of existence and uniqueness
First, we notice that we have an implicit formula for n(t, x):
n(t, x) = n0(x)e
∫ t
0 R(x,ρ(s)) ds (10)
which shows that n is necessarily non-negative.
Theorem 3.2. Assume, as in Lemma (3.1), that n0 is such that ρm ≤ ρ0 := ∫X n0(x) dx ≤ ρM .
Then, there exists a unique non-negative global solution n to the equation (7).
It furthermore satisfies:
ρm ≤ ρ(t) ≤ ρM for all t > 0.
Proof. The proof is based on the Banach fixed point theorem.
First step. We start by defining the appropriate Banach space. For T > 0 that will be chosen
later, we consider the Banach space
E := C
(
[0 , T ], L1(X)
)
endowed with the norm ‖m‖E := sup
0≤t≤T
‖m(t)‖L1(X)
We also consider the following closed subset of E:
F := {m ∈ E /m ≥ 0 and ‖m‖E ≤ K}
where K > ρM is some constant.
Second step. We now build the application. Let m be a fixed element in F , and let us define
ρ˜(t) =
∫
X
m(t, x) dx
For fixed x0 ∈ X, we consider the solution γx0 to the following differential equation:{
dγx0
dt = R (x, ρ˜(t)) γx0
γx0(0) = n
0(x0)
which is global on [0 , T ]. 1
1Note that this function is defined as an integral of m, and thus does not depend on the representative for the
a.e. equivalence relation.
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We now define for all (t, x) in [0 , T ] × X the function n(t, x) := γx(t), thus building an
application Φ through Φ(m) := n.
Third step. We show that Φ maps F onto itself.
The equation (3.1.2) can be solved explicitly by
n(t, x) = n0(x)e
∫ t
0 R(x,ρ˜(s)) ds
It shows both n ≥ 0 and n ∈ E. As in the a priori estimates, we bound ∂n∂t (t, x) and integrate
to get
dρ
dt
(t) ≤
[
max
x∈X
R (x, ρ˜(t))
]
ρ(t)
Using the bound on the initial data, together with max
x∈X
R (x, ρ˜(t)) ≤ max
x∈X
R (x, 0) =: λ, we
get
ρ(t) ≤ ρMeλT
To obtain n ∈ F , it only remains to choose T small enough so that ρMeλT ≤ K.
Fourth step. Let us now prove that Φ is a strong contraction from F onto F whenever T is
small enough. Let (m1,m2) ∈ F 2 and (n1, n2) its image by Φ. We define ρ˜i as before for i = 1, 2.
(n1 − n2)(t, x) = n0(x)
[
e
∫ t
0 R(x,ρ˜
1(s)) ds − e
∫ t
0 R(x,ρ˜
2(s)) ds
]
Now, since the argument of the exponentials can be bounded by λT , the mean value theorem
yields
|(n1 − n2)|(t, x) ≤ n0(x)eλT
∣∣∣∣∫ t
0
[
R
(
x, ρ˜1(s)
)−R (x, ρ˜2(s))] ds∣∣∣∣
≤ Cn0(x)eλT
[∫ T
0
∣∣ρ˜1(s)− ρ˜2(s)∣∣ ds ds]
≤ Cn0(x)TeλT ‖m1 −m2‖E (11)
by the mean value theorem again, with C := sup(x,ρ)∈X×[0 ,K]
∣∣∂R
∂ρ (x, ρ)
∣∣. We now integrate
with respect to x and take the supremum over t ∈ [0 , T ] in (11) to uncover
‖n1 − n2‖E ≤ CρMTeλT ‖m1 −m2‖E
This provides us with the contracting property for Φ whenever T is small enough.
Fifth step. We now conclude by noticing that T has been chosen small independently of the
initial data, so that the argument can be iterated on [0 , T ], [T , 2T ], etc.
By the a priori estimates of the lemma, we also iteratively have the bounds stated in the
theorem.
3.2 Asymptotics
3.2.1 Convergence for ρ
The previous hypotheses are enough to show that ρ converges. It is also possible to identify the
limit as the maximal capacity ρM , if we simply assume the following: among the xM s such that
R(xM , ρM ) = 0, there exists x0 such that n0 does not vanish in a neighborhood of x0.
Note that this is not really a restriction, since we can for example assume that n0 is continuous,
so that n0(x0) > 0 would be enough for our purpose (and if it were not true, we could define
the set X and ρM differently, removing the traits for which n0 is zero).
To show that ρ converges, we will prove that it has bounded total variation on R+ (see Ap-
pendix A for a reminder of the fact that a BV function on R+ converges).
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Proposition 3.3. ρ is a BV function and thus converges. Furthermore, its limit is ρM .
Proof. We define q :=
dρ
dt
and we need to prove that q ∈ L1(R+). We differentiate dρ
dt
=
∫
nR
to obtain:
dq
dt
=
∫
nR2 +
(∫
n
∂R
∂ρ
)
q
It provides an upper bound for the negative part of q (see Appendix B):
dq−
dt
≤
(∫
n
∂R
∂ρ
)
q−
≤ −dρmq−
thanks to the hypothesis in (9) and the lower bound on ρ. We conclude that the negative part
of q vanishes exponentially. Together with the upper bound on ρ, this proves the first result
(see Appendix A for a proof that an upper bounded function whose derivative has integrable
negative part, is BV ).
We denote the limit with ρ?, and argue by contradiction by assuming ρ? < ρM .
Let  > 0 and t0 > 0 such that ρ(t) ≤ ρM −  for all t > t0. Then, for x ∈ V a neighborhood of
x0 such that R(x0, ρM ) = 0 and t > t0, we can write
∂n
∂t
(t, x) = R (x, ρ(t))n(t, x)
≥ R (x, ρM − )n(t, x)
≥ η n(t, x)
for some η > 0 (choosing  small enough). This now implies for t > t0
ρ(t) ≥
∫
V
n(t, x) dx ≥
[∫
V
n0(x)
]
eη(t−t0)
which contradicts the upper bound on ρ since the right hand side goes to +∞.
3.2.2 Convergence for n
We now assume that there exists a single trait x0 such that R(·, ρM ) vanishes, which means
that one trait has a selective advantage over all others. Our aim is to prove that the population
asymptotically concentrates in x0. The idea is that for all the other traits, n(t, x) goes to 0
exponentially. The correct statement is given in the theorem hereafter:
Theorem 3.4. Suppose there is a unique trait x0 such that R(x0, ρM ) = 0. Then the population
concentrates in x0 with mass ρM , i.e.
n(t, x) ⇀ ρMδx0
Remark 3.5. By the weak convergence here, we mean in the sense of the bounded measures
M1(X), defined as the (topological) dual of C(X) (the set of continuous functions on X).
Proof. As explained in the remark, we have to show that
∀φ ∈ C(X),
∫
X
n(t, x)φ(x) dx→ ρMφ(x0)
Note that we already know, by the Banach-Alaoglu theorem, that we have converging sub-
sequences since ∀t ≥ 0, ‖n(t, ·)‖L1(X) ≤ ρM : the family (n(t, ·))t≥0 is thus uniformly bounded
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in M1(X). Here, we won’t use this result as we can directly determine the limit.
Let φ ∈ C(X). From∣∣∣∣∫
X
n(t, x)φ(x) dx− ρMφ(x0)
∣∣∣∣ ≤ ∣∣∣∣∫
X
n(t, x)φ(x) dx− φ(x0)
∫
X
n(t, x) dx
∣∣∣∣
+
∣∣φ(x0)(ρ(t)− ρM )∣∣ (12)
and since the last term goes to 0, it remains to show that the first one does as well.
Let  > 0. We choose η > 0 such that B(x0, η) ⊂ X and
∣∣φ(x) − φ(x0)∣∣ ≤  as soon as∣∣x− x0∣∣ ≤ η, split the integral and estimate both terms:∣∣∣∣∫
X
n(t, x)(φ(x)− φ(x0)) dx
∣∣∣∣ ≤ 2‖φ‖∞
(∫
X\B(x0,η)
n(t, x) dx
)
+ ρM  (13)
As R(·, ρ) converges uniformly to R(·, ρM ) on X\B(x0, η) and maxx∈X\B(x0,η)R(·, ρM ) =:
−α < 0, we can state that for t large enough, say t ≥ t0:
∀x ∈ X\B(x0, η), R(x, ρ) ≤ −α
2
(14)
which allows us to write : n(t, x) ≤ n(t0, x)e−α2 (t−t0) on X\B(x0, η) from the equation on n.
Therefore,
∫
X\B(x0,η) n(t, x) dx goes to 0 and this completes the proof.
Remark 3.6. The proof also works if x0 does not lie in the interior of X, for example if X is
some interval of R and if x0 is one of its extremities.
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4 System of two integro-differential equations
Canonical equation and goals
We now wish to investigate the dynamics of the coupled equations (without advection and
diffusion), which we recall here with subscripts 1 and 2 rather than A and C. x can be taken as
a variable for the traits structuring both populations, since they are independent.
∂n1
∂t
(t, x) = [R1 (x, ρ1(t)) +R12 (x, ϕ2(t))]n1(t, x)x ∈ X, t > 0,
∂n2
∂t
(t, x) = [R2 (x, ρ2(t)) +R21 (x, ϕ1(t))]n2(t, x)x ∈ X, t > 0,
(15)
with x ∈ X as before and initial conditions
n1(0, x) = n
0
1(x) ≥ 0, x ∈ X,
n2(0, x) = n
0
2(x) ≥ 0, x ∈ X,
(16)
Also recall the definitions, for i = 1, 2:
ρi(t) =
∫
ni(t, x)dx, ϕi(t) =
∫
ψi(x)ni(t, x)dx, ψi(·) ≥ 0. (17)
The simpler model we have in mind is given by:
Ri (x, ρi(t)) = ri(x)− diρi(t) (18)
and
R12 (x, ϕ2) = s1(x)ϕ2, R21 (x, ϕ1) = s2(x)ϕ1 (19)
In agreement with the biological framework, we will study the mutualistic case, i.e. we
assume:
R12(·), R21(·) ≥ 0 (20)
These functions must also vanish when the other population is absent, in other words
∀x ∈ X, R12(x, 0) = R21(x, 0) = 0 (21)
Also, for the mathematical analysis of these equations, we have so far focused on the case
ψ1,2 ≡ 1, i.e. I1,2 ≡ ρ1,2. Indeed, this case allows for fruitful comparisons with the usual mutu-
alistic Lotka-Volterra 2 × 2 system (at the level of ρ). This is why we start by recalling some
classical facts about these systems, in section 4.1.
In section 4.2, under new assumptions made natural by the Lotka-Volterra system, we prove
a-priori bounds, existence and uniqueness for the general equation.
In section 4.3, under some stronger hypotheses, we prove BV bounds for ρ1,2 to get convergence
for the total populations of cells 1 and 2.
4.1 Mutualistic 2 × 2 Lotka-Volterra systems
Considering the simpler case (18, 19) and assuming that all coefficients are constant in x, the
equations boil down to the dynamics of (ρ1, ρ2), which after integration is given by the following
classical 2 × 2 Lotka-Volterra system:
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
dρ1
dt
=
[
r1 − d1ρ1 + C12ρ2
]
ρ1,
dρ2
dt
=
[
r2 − d2ρ2 + C21ρ1
]
ρ2,
(22)
This is why we wish to recall some classical results on such systems and their proof (which
might in turn provide useful ideas for the general system).
With positive initial conditions ρ0i > 0 for i = 1, 2, the exponential-like structure ensures
that ρ1 and ρ2 remain positive for all times for which they are defined.
4.1.1 Possible blow-up
Suppose all coefficients are equal, and that the initial conditions for ρ1 and ρ2 are the same,
so that we can write ρ1 = ρ2 =: ρ for all times for which the solution is defined. ρ satisfies
the equation dρ∂t (t, x) = rρ − (d − C)ρ2 for which it is clear there is explosion if d < C. More
explicitly, if d < C and setting γ := C − d > 0, we have dρdt ≥ γρ2. If we integrate, we find that
ρ blows up before T := 1γρ(0) .
Directly finding an extension in the general case (22) in order to avoid blow-up can be achieved
through studying the steady states. There are four steady states, three of which are always in
the quadrant of interest : (0, 0), (ρM1 , 0) and (0, ρM2 ) where ρMi , i = 1, 2 stand for the carrying
capacity for populations 1 and 2. They are given by ρMi =
ri
di
, i = 1, 2. The last steady state
(ρˆ1, ρˆ2) is: 
ρˆ1 =
d2r1 + C12r2
d1d2 − C12C21 ,
ρˆ2 =
d1r2 + C21r1
d1d2 − C12C21 ,
(23)
and is of interest if and only if
d1d2 > C12C21 (24)
which turns out to be the proper generalization of the non blow-up condition exhibited before.
It is also worth mentioning that ρMi < ρˆi for i = 1, 2, which means that, as the intuition would
suggest, mutualism leads to a larger steady state than without interaction.
Standard phase plane arguments show that if the nullclines r1−d1ρ1 +C12ρ2 = 0 and r2−d2ρ2 +
C21ρ1 = 0 do not intersect in the positive quadrant (i.e. if d1d2 ≤ C12C21), both populations
grow unboundedly. We thus focus in the case where (24) is fullfilled in what follows, a case
which will turn out to find a natural generalization for the general equation (15).
4.1.2 Convergence in the case (24)
Through a classical Lyapunov functional for Lotka-Volterra systems and under the condition
(24), we prove simultaneously that the solution does not blow-up and that the steady state
(ρˆ1, ρˆ2) is globally asymptotically stable (in (R?+)2).
Definition 4.1. For a given x? > 0, we define the function
Vx? : R?+ −→ R+
x 7−→ x− x? − x? ln
( x
x?
) (25)
Remark 4.2. The function Vx? has the following properties
• Vx? is a C1 function;
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• Vx?(x) > 0 for x 6= x? and Vx?(x?) = 0;
• Vx? is a proper function.
This function being now defined, we can prove the:
Proposition 4.3. Suppose that the condition (24) is satisfied. Then (ρ1, ρ2) is globally defined
and the steady state (ρˆ1, ρˆ2) is globally asymptotically stable.
Proof. Let αi > 0, i = 1, 2 (to be chosen later), and V (ρ1, ρ2) := Vρˆ1(ρ1) + Vρˆ2(ρ2), which is
also a C1 proper function (on (R?+)2) that satisfies V (ρ1, ρ2) > 0 for (ρ1, ρ2) 6= (ρˆ1, ρˆ2) and
V (ρˆ1, ρˆ2) = 0.
V is our candidate to be a Lyapunov function for the system (23) and we thus compute
d
dtV (ρ1, ρ2) for admissible t > 0 (bearing in mind that we don’t know yet that the solutions
are globally defined).
d
dt
V (ρ1, ρ2) = α1
(
1− ρˆ1
ρ1
)
dρ1
dt
+ α2
(
1− ρˆ2
ρ2
)
dρ2
dt
= α1 (ρ1 − ρˆ1) [r1 − d1ρ1 + C12ρ2] + α2 (ρ2 − ρˆ2) [r2 − d2ρ2 + C21ρ1]
= α1 (ρ1 − ρˆ1) [−d1 (ρ1 − ρˆ1) + C12 (ρ2 − ρˆ2)]
+ α2 (ρ2 − ρˆ2) [−d2 (ρ2 − ρˆ2) + C21 (ρ1 − ρˆ1)]
The last equality is obtained by adding 0 = r1 − d1ρˆ1 +C12ρˆ2 = r2 − d2ρˆ2 +C21ρˆ1, the very
definition of the steady state (ρˆ1, ρˆ2).
We now change variables by setting : u = ρ1 − ρˆ1, v = ρ2 − ρˆ2 so that the equation writes
d
dt
V (ρ1, ρ2) = α1u(−d1u+ C12v)α2v(−d2v + C21u)
= − [α1d1u2 − (C12α1 + C21α2)uv + α2d2v2]
= −1
2
XtAX
with X =
(
u
v
)
and A =
(
2α1d1 − (C12α1 + C21α2)
− (C12α1 + C21α2) 2α2d2
)
.
If we find (α1, α2) such thatA, which is symmetric, is also definite positive, then ddtV (ρ1, ρ2) ≤
0 with equality if and only if (u, v) 6= (0, 0), i.e. if and only if (ρ1, ρ2) = (ρˆ1, ρˆ2). Consequently,
it remains to find (α1, α2) such that A has positive determinant (since it already has positive
trace) and we will have found a Lyapunov function for the system, proving both claims of the
theorem.
Now, det(A) = 4α1α2d1d2 − (C12α1 + C21α2)2. Choosing α1 = 1C12 and α2 = 1C21 , we have to
check that 4 d1d2C12C21 > 4, which is indeed true thanks to assumption (24).
Remark 4.4. From classical Cauchy-Lipschitz arguments, it is easy to check that if ρ1(0) ≤ ρˆ1
and ρ2(0) ≤ ρˆ2, then we have for all times ρ1 ≤ ρˆ1 and ρ2 ≤ ρˆ2.
4.2 Existence and uniqueness
4.2.1 Regularity and non blow-up assumptions
We start by making regularity assumptions. Since we wish to study how the coupling affects
the behaviour of a single equation, it is natural to keep the assumptions for R1, R2, n01 and n02,
i.e. we assume for i = 1, 2 that
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{
Ri ∈ C1
(
Rd × R)
n0i ≥ 0 ∈ L1(X)
(26)
and that there exist ρmi , ρ
M
i , di such that
∀x ∈ X, Ri(x, ρmi ) ≥ 0
∀x ∈ X, Ri(x, ρMi ) ≤ 0
∂Ri
∂ρi
≤ −di
(27)
As for the coupling functions R12 and R21, we will assume they are C1
(
Rd × R) functions,
and there exist some non-negative constants C12, C21 such that
∂R12
∂ρ2
≤ C12
∂R21
∂ρ1
≤ C21
(28)
If we are in the model case (18), with constant coefficients in x, it is clear that ρ1, ρ2 satisfy
a classical Lotka-Volterra system as in section (2). This is the reason why we will assume
d1d2 > C12C21 (29)
which (as will be proved thereafter) will be the condition under which blow-up is avoided. The
Lotka-Volterra case then shows that these are optimal conditions.
Still from the simpler case with constant coefficients, it is possible to infer possible bounds for
ρ1, ρ2. Indeed, if R1 (x, ρ1) = r1 − d1ρ1 and R12 (x, ρ2) = C12 ρ2 (and similarly for the second
equation), then ρM1,2 =
r1,2
d1,2
. From the values ρˆ1 and ρˆ2, we thus define ρ¯1 and ρ¯2 (by substituting
d1,2 ρ
M
1,2 for r1,2): 
ρ¯1 =
d2
(
d1ρ
M
1 + C12ρ
M
2
)
d1d2 − C12C21 ,
ρ¯2 =
d1
(
d2ρ
M
2 + C21ρ
M
1
)
d1d2 − C12C21
(30)
Consequently, we have:
−d1
(
ρ¯1 − ρM1
)
+ C12ρ¯2 = −d2
(
ρ¯2 − ρM2
)
+ C21ρ¯1 = 0 (31)
4.2.2 A priori bounds for ρ1 and ρ2
In order to prove that ρ1 and ρ2 are indeed bounded above by ρ¯1 and ρ¯2 respectively, we use
the sub-solution and supersolution technique.
The classical theorem of sub-solution and supersolution for ODEs is usually stated in the case
of a one-dimensional ODE. Its extension to a system requires some monotonicity assumptions,
this is why we state (or recall) the result thereafter (in a fairly general fashion that is sufficient
for our purpose here):
Lemma 4.5. Let I be an interval of R. Let f1, f2 : I × R2 → R be two functions that satisfy
the hypotheses of Cauchy Lipschitz (i.e. they are continuous and locally Lipschitz with respect to
the second variable). Also suppose that for all (t, x1, x2) ∈ I × R2, the functions f1(t, x1, ·) and
f2(t, ·, x2) are non-decreasing. Let (x1, x2) a couple of functions solving the following Cauchy
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problem 
dx1
dt
= f1(t, x1, x2)
dx2
dt
= f2(t, x1, x2)
x1(t0) = x
0
1, x2(t0) = x
0
1
on some sub-interval J of I with t0 ∈ J .
Suppose we have a sub-solution of the equation on J , i.e. a couple of functions (u1, u2) such
that, on J : 
du1
dt
≤ f1(t, u1, u2)
du2
dt
≤ f2(t, u1, u2)
u1(t0) ≤ x01, u2(t0) ≤ x01
Then, for all t ≥ t0, t ∈ J :
u1(t) ≤ x1(t), u2(t) ≤ x2(t)
We now state the theorem:
Theorem 4.6. Suppose we have a solution of (15) in
(
C
(
R+, L1(X)
))2, and that the initial
data is such that for i = 1, 2 : ρmi ≤ ρ0i :=
∫
X n
0
i (x) dx ≤ ρ¯i.
Then, for all t > 0 and i = 1, 2:
ρmi ≤ ρi(t) ≤ ρ¯i
Proof. The lower bounds are straightforward, as the sign assumption (20) ensures that the tech-
nique used for the single equation is still valid.
For the upper bound, we estimate the different terms (focusing on the first equation).
• Using assumption (21), R12 (x, ρ2) ≤ C12 ρ2 for all x.
• For x ∈ X, R1 (x, ρ1) = R1
(
x, ρM1
)
+ ∂R1∂ρ1 (x, ρ˜)
(
ρ1 − ρM1
)
for a certain ρ˜ depending on
x. This allows us to bound by (27) R1 (x, ρ1) ≤ ∂R1∂ρ1 (x, ρ˜)
(
ρ1 − ρM1
)
. At this stage, we
have not managed to compare the equation with the expected "Lotka-Volterra" one, i.e.
we cannot write R1 (x, ρ1) ≤ −d1
(
ρ1 − ρM1
)
in general. Indeed, we have to distinguish at
whether ρ1 is above ρM1 to be able to do so.
First note that if C12 = 0, then R12 ≡ 0 and the bound follows from the single equation case
(since ρ¯1 = ρM1 if C12 = 0). That allows us to consider only the case of C12, C21 > 0, which is
equivalent to ρ¯1 > ρM1 , ρ¯2 > ρM2 .
For a generic interval I := [t1 , t2] (t2 > t1) suppose that ρ1 and ρ2 are above ρM1 and ρM2
respectively, globally on I.
Then, we can write on I from the previous estimations above:
dρ1
dt
≤ [− d1 (ρ1 − ρM1 )+ C12ρ2] ρ1
22
The same reasoning for the second equation implies that (ρ1, ρ2) satisfies the following differential
system of inequalities on I:
dρ1
dt
≤ [− d1 (ρ1 − ρM1 )+ C12ρ2] ρ1
dρ2
dt
≤ [− d2 (ρ2 − ρM2 )+ C21ρ1] ρ2
(ρ1, ρ2) is thus a sub-solution of the system
dρ˜1
dt
=
[− d1 (ρ˜1 − ρM2 )+ C12ρ˜2] ρ˜1,
dρ˜2
dt
=
[− d2 (ρ˜2 − ρM2 )+ C21ρ˜1] ρ˜2,
with initial conditions chosen to be ρ˜1(t1) = ρ1(t1), ρ˜2(t1) = ρ2(t1).
This system is a Lotka-Volterra one, as introduced in the previous section, whose solutions are
thus globally defined and they remain below ρ¯1 and ρ¯2 respectively. The functions involved
clearly satisfy the assumptions of the lemma, allowing us to state:
∀t ∈ I, ρ1(t) ≤ ρ˜1(t) ≤ ρ¯1, ρ2(t) ≤ ρ˜2(t) ≤ ρ¯2
We can now conclude the theorem : suppose by contradiction that there exists t0 > 0 such that
ρ1(t0) > ρ¯1 or ρ2(t0) > ρ¯2.
We can thus define t? := inf {t < t0 such that ρ1(t) > ρ¯1 or ρ2(t) > ρ¯2}, and the assumption
above ensures that t? < t0. Also, ρ1(t?) = ρ¯1 or ρ2(t?) = ρ¯2 and without loss of generality we
can consider only the case when ρ1(t?) = ρ¯1.
We compute
dρ1
dt
(t?) =
[− d1 (ρ¯1 − ρM1 )+ C12ρ2(t?)] ρ¯1
= C12 (ρ2(t
?)− ρ¯2) ρ¯1
If ρ2(t?) < ρ¯2, then the right hand side is negative, which means that in the immediate past of
t1, ρ1 was strictly above ρ¯1, a contradiction.
If ρ2(t?) = ρ¯2, this is not enough to conclude.
However, thanks to ρ¯1 > ρM1 , ρ¯2 > ρM2 , this implies that, locally around t? (say on I = [t? , t2]
with t2 > t?), ρ1 > ρM1 and ρ2 > ρM2 , so that the differential system of inequalities holds true
on I. From that we deduce that both functions remain below ρ¯1, ρ¯2 on I, which would imply
t? ≥ t2, a contradiction.
Remark 4.7. The proof above also works if we had kept the functions ψ in the definition of
functions ϕ. If they are bounded on X by ψMi , then ρ¯i (i = 1, 2) has to be changed by substituting
C12ψ
M
1 to C12 and C21ψ
M
2 to C21, respectively.
4.2.3 Existence and uniqueness
As the proof of existence and uniqueness for the system (15) resembles the one used in the single
equation case, we do not give it here.
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4.3 Asymptotics
4.3.1 Convergence for ρ1 and ρ2
In order to prove that both ρ1 and ρ2 converge, we use the same approach as for equation, i.e.
we prove that they are BV functions on R+. However, there is no reason here that this limit
should be ρ¯ as the bounds ∂Ri∂ρi ≤ −di and
∂Rij
∂ρ2
≤ Cij are not necessarily attained for the same
trait.
More importantly, the convergence is obtained under a restrictive condition.
Proposition 4.8. If
d1d2ρ
m
1 ρ
m
2 > C12C21ρ¯1ρ¯2, (32)
then ρ1 and ρ2 are BV functions and thus converge.
Proof. We define q1 :=
dρ1
dt
and differentiate
dρ1
dt
=
∫
n1 [R1 +R12] to obtain:
dq1
dt
=
∫
n1 [R1 +R12]
2 +
(∫
n1
∂R1
∂ρ1
)
q1 +
(∫
n1
∂R12
∂ρ2
)
q2
It provides an upper bound for the negative part of q1:
d(q1)−
dt
≤
(∫
n1
∂R1
∂ρ1
)
(q1)− +
(∫
n1
∂R12
∂ρ2
)
(q2)−
≤ −d1ρ1(q1)− + C12ρ1(q2)−
≤ −d1ρm1 (q1)− + C12ρ¯1(q2)−
Together with the same inequalities for the second equation, this yields the following system:
d(q1)−
dt
≤ −d1ρm1 (q1)− + C12ρ¯1(q2)−
d(q2)−
dt
≤ −d2ρm2 (q2)− + C21ρ¯2(q1)−
Using the lemma (4.5) (or more precisely a generalization of it), this implies that we have globally
on R+: (q1)− ≤ y1 and (q2)− ≤ y2 where (y1, y2) solves the corresponding system with same
initial conditions: 
dy1
dt
= −d1ρm1 y1 + C12ρ¯1y2
dy2
dt
= −d2ρm2 y2 + C21ρ¯2y1
From assumption (32), the matrix associated to this linear differential system has negative
trace and positive determinant. The functions y1 and y2 consequently both converge exponen-
tially to 0, and so do (q1)− and (q2)−.
The upper bound on ρ1 and ρ2 finally ensures that both functions are BV .
Remark 4.9. Note that the condition (32) is stronger than (24). Also note that the first (and
thus, the latter) is automatically verified if the interspecific competition is very small compared
to the intraspecific competition.
At this stage, it is not clear if oscillations can exist if (24) is met, but not (32). No oscillations
have been observed numerically in this case.
Remark 4.10. By differentiating u = max ((q1)−, (q2)−), one can check that the conclusion
also holds in the case where
d1ρ
m
1 + d2ρ
m
2 > C12ρ¯1 + C21ρ¯2, (33)
24
5 Parametrization of the model
We now wish to investigate techniques to parametrize the canonical model we have introduced
in the second section. By parametrizing, we mean first identify key terms in the equations
(and, doing so, neglect some of them if necessary), then estimate the functions involved in the
remaining terms.
Two strategies will be presented: the first one consists of trying to obtain explicit formulas for
the solutions in a simplified setting, the second to produce numerical simulations.
5.1 With explicit formulas
5.1.1 Main ideas and model simplification
Although the following calculations might be generalized to a system (which would require
further questionable simplifications), we here focus on trying to get explicit solutions for a single
equation. This can allow for estimating parameters or terms which are not involved in the
interaction. We will consider the following equation structured by x ∈ R, which can be seen as
a simplification of the equation (1):
∂n
∂t
(t, x) + v
∂n
∂x
(t, x) = β
∂2n
∂x2
(t, x) +R (x, ρ(t))n(t, x). (34)
R (x, ρ) :=
(
γ − x2)− dρ (35)
and Gaussian initial condition of total mass ρ0, mean µ0 and standard deviation σ0. In other
words, the initial condition is:
n(0, x) = n0(x) :=
ρ0√
2piσ0
e
− (x−µ0 )
2
2σ2
0 (36)
The idea is then to search for a solution n(t, x) which has a Gaussian shape for every t > 0. This
probability distribution is natural since it solves the Fokker-Planck equation, i.e. the previous
one without the R term. It also has biologically grounds, because a classical argument is to say
that complex systems can be seen as the result of adding many independent random events. In
such a case, assuming that these events are independent and identically distributed, the central
limit theorem ensures that the limiting distribution should be Gaussian.
Here is a list of the simplifications, the reason behind each of them and potential drawbacks.
• x ∈ R
This assumption is needed in order to have an Gaussian solution. Although it might
seem very restrictive, or in contradiction with the fact that a compact set of traits can be
expected, this feature of the new model does not necessarily lead to a great loss of mass ρ:
the selection term R can ensure that the population remains centered on traits that make
sense biologically. The tails at infinity, as it is usually done in such cases, do not make
sense biologically but can be neglected. A real drawback in terms of modelling is the fact
that if x is seen as the concentration level of a protein, concentration of the population
around a very low level of expression cannot really be expected to look Gaussian. Also, it
is not necessarily the case that the initial condition is Gaussian.
• Constant functions v and d
From comparing the model (34) to (1), one can see that we here take constant velocity
v(x) := v and constant death rate d(x) := d. Both make computations possible. The
first doesn’t allow for modelling the fact that near boundaries (i.e. traits that cannot be
overpassed biologically), we can expect that the velocity vanishes. The second is usual for
the modelling of cells.
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• Shape of R
The shape of R, especially the birth rate given by γ − x2, means that the trait x = 0
has a selective advantage over all others. A polynomial of order at most 2 is necessary to
perform calculations.
5.1.2 Explicit formulas
From the previous considerations, we thus look for a Gaussian solution to equation (34), given
by:
n(t, x) =
ρ(t)√
2piσ(t)
e
− (x−µ(t))2
2σ(t)2 (37)
Plugging this formula into the equation and solving several differential equations for functions
σ, µ and ρ leads to an explicit solution. Also, we prove that all three functions converge. The
full computations and proofs can be found in appendix C.
Formula for σ
We define a := 2 (β)
1
2 and
σ∞ :=
(
β

) 1
2
. (38)
The variance σ2 is given by
σ2(t) =

σ2∞ tanh (α+ at) if σ0 < σ∞ with α := arctanh
(
σ20
σ2∞
)
σ2∞ if σ0 = σ∞
σ2∞ (tanh (α˜+ at))
−1 if σ0 > σ∞ with α˜ := arctanh
(
σ2∞
σ20
) (39)
Whatever the case, limt→+∞ σ(t) = σ∞, and the convergence is exponential and controlled by
2a = 4 (β)
1
2 when the variance is not identically equal to σ∞.
The asymptotic value is increasing with the rate of random epimutations, decreasing with the
strength of the selection. However, the speed of convergence to this asymptotic value is increas-
ing with both.
Formula for µ
The mean µ is given by
µ(t) = e−2
∫ t
0 σ
2(s) ds
[
µ0 + v
∫ t
0
e2
∫ s
0 σ
2(z) dz ds
]
. (40)
This expression can be made more explicit through cumbersome integrations (see the appendix
for an example).
More interesting is the fact that µ has a limit, given by
µ∞ :=
v
a
=
v
2 (β)
1
2
(41)
Thus, although x = 0 has a selective advantage, it is not selected: there is a compromise between
the drift v and the selection strength  which leads to the selection of another trait.
Formula for ρ
Defining the function Q := γ − (σ2 + µ2), we have a formula for the total mass ρ:
ρ(t) =
(
e−
∫ t
0 Q(s) ds
[
1
ρ0
+ d
∫ t
0
e
∫ s
0 Q(z) dz ds
])−1
(42)
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The asymptotic behaviour of ρ depends on Q∞ := γ − 
(
σ2∞ + µ2∞
)
.
If Q∞ < 0, then ρ goes to 0: the whole population dies. If Q∞ > 0, ρ converges to ρ∞ := dQ∞ ,
i.e. to
ρ∞ =
1
d
[
γ −
(
(β)
1
2 +
v2
4β
)]
. (43)
Note that the extinction is possible, since the birth rate γ − x2 becomes negative for x great
enough (which can be seen as a way of saying that such individuals are not viable). The formula
for Q∞ is coherent with this idea: γ has to be great enough, notably with respect to the
asymptotical mean µ∞ (the selected trait).
5.2 By means of numerical simulations
5.2.1 Numerical scheme
To present how the equation (3) can be simulated, we focus on the principles behind the simula-
tion of a single equation, i.e. (1) since it generalizes immediately to two equations and it makes
notations simpler. We recall the equation thereafter, together with the Neumann boundary
conditions and initial conditions:
∂n
∂t
(t, x) +
∂
∂x
(v(x)n(t, x)) = β
∂2n
∂x2
(t, x) +R (x, ρ(t))n(t, x), t > 0, x ∈ [0 , 1]
n(0, x) = n0(x), x ∈ [0 , 1]
∂n
∂t
(t, 0) =
∂n
∂t
(t, 1) = 0, t > 0.
(44)
We discretize the time t on some interval [0 , T ] and x in [0 , 1] as follows: for given steps ∆t
and ∆x such that P := T∆t and K :=
1
∆x are integers, we denote tp := p∆t and xk = k∆x for
generic times and traits where p = 0, . . . , P and k = 0, . . . ,K.
The goal is to approach n(tp, xk) for such k and p’s by values that we will denote n
p
k, thanks to
a time-splitting scheme.
We also define n0k = n
0(xk), and the scheme consists of recursively computing n
p
k for all
0 ≤ k ≤ K, incrementing p from the value 0 to P − 1.
First step: diffusion and advection
We start by taking into account the diffusion and advection terms only, thus defining interme-
diate values np+
1
2
k , thanks to an explicit finite-difference scheme:
n
p+ 1
2
k − npk
∆t
= −v(xk)n
p
k − v (xk−1)npk−1
∆x
+ β
npk+1 − 2npk + npk−1
∆x2
for all 1 ≤ k ≤ K − 1. This scheme is stable if both following CFL conditions hold:
‖v‖L∞ ∆t
∆x
< 1 and β
∆t
∆x2
< 1.
Neumann boundary conditions are ensured thanks to np+
1
2
0 = n
p+ 1
2
1 and n
p+ 1
2
K = n
p+ 1
2
K−1.
Second step: selection
To get a more stable scheme (but obtaining an explicit CFL condition is difficult there) for
discretizing the selection term, we define R+ := max (0, R) and R− := max (0,−R) and use an
implicit-explicit finite-difference scheme:
np+1k − n
p+ 1
2
k
∆t
= R+
(
xk, ρ
p+ 1
2
)
n
p+ 1
2
k −R−
(
xk, ρ
p+ 1
2
)
np+1k
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for all 0 ≤ k ≤ K. Here ρp+ 12 is the approximation through the rectangle method of the value
of ρ at the intermediate time p+ 12 . In other words, ρ
p+ 1
2 = ∆x
∑K
k=0 n
p+ 1
2
k .
5.2.2 Examples of results
Our aim is to fix the parameters and to enlighten the role of each term the dynamics of n and
ρ through presentation of simulations of the model (1). This is done in the case of a single
equation to understand the main features, as data is still expected for the co-cultures in order
to compare them to the model (3). Here, n is seen as the cancer cell population with phenotype
x ranging from 0 (epithelial) to 1 (mesenchymal).
The parameters and functions involved in the model are v(x) = 5.10−3(1− x2), β = 1.10−3
and R(x, ρ) = r(x)− dρ with r(x) = 2.5.10−2(2− x), d = 2.5.10−2.
Thus, 0 here has a selective advantage, but the drift pushes x to the right: it can be seen as
a modelling of the fact that epithelial cells have a selective advantage if not under stress, but
that the environment (adipocytes, for example) make them actively change their phenotype to
a mesenchymal one.
Initial condition is given by n0(x) = C√2piσ0 e
− x2
2σ20 with initial standard deviation σ0 = 0.02
and C a normalizing constant chosen so that ρ(0) = 1.
Thus, we start with a total mass equal to 1, and the phenotype is concentrated in 0.
We take T = 1000 and discretization parameters ∆t = 5.10−4 and ∆x = 1.10−2. For all
simulations, we plot ρ(·) and n(t, ·) for t = 0, t = T2 and t = T .
1. Selection only
By selection only, we mean taking temporarily β = 0 and v ≡ 0.
Figure 8: Numerical simulation of the solution to (1) without diffusion and advection.
From the third section, we are supposed to have convergence of ρ and of n to a Dirac mass
in 0, as it is indeed the case. Also, the limit for ρ is ρM with the notations of the third section.
Here ρM = 2 and this is what we observe numerically.
28
2. Selection and advection
By selection and advection, we mean taking temporarily β = 0.
Figure 9: Numerical simulation of the solution to (1) without diffusion.
Here, we see that the advection term is strong enough to lead to a selection of x = 1, in
the sense of convergence of n to a Dirac mass in 1. The asymptotic mass is different from the
previous case.
3. Selection, advection, and diffusion
Now, all terms are considered.
Figure 10: Numerical simulation of the solution to (1).
With diffusion, the trait 1 is still more selected than the others. However, we do not observe
convergence to a Dirac mass: there is still a limiting profile but it lies in L1 ([0 , 1]). Thus, we
also still have convergence of ρ.
Let us now show numerically that with a weaker advection (i.e. v(x) = 5.10−5(1−x2)), there can
be selection of a trait which is neither 0 nor 1. There is a thus a compromise between advection
and selection, as in the explicit computations on the whole R. The following simulations are
performed with no diffusion (β = 0) and we take T = 20000. The selected trait is approximately
0.2.
Figure 11: Numerical simulation of the solution to (1) without diffusion, and with lower
advection.
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A BV functions on R+
We here recall some results about BV functions on R+, i.e. functions whose derivative is
integrable on R+.
The most important one is of course:
Proposition A.1. Let ρ be a BV function on R+. Then it has a limit as t goes to +∞.
Proof. Let (tn)n∈N be any sequence going to +∞. Then ρ(tn) − ρ(tk) =
∫ tk
tn
ρ′(u) du, which
yields:
∣∣ρ(tn)− ρ(tk)∣∣ ≤ ∣∣∣∣∫ tk
tn
∣∣ρ′(u)∣∣ du∣∣∣∣
≤
∫ +∞
tn
∣∣ρ′(u)∣∣ du+ ∫ +∞
tk
∣∣ρ′(u)∣∣ du
Both quantity go to 0 as n and k go to +∞ respectively, thanks to the integrability of f ′. It
proves that (ρ(tn))n∈N is a Cauchy sequence, which thus has a limit. We denote it by l.
Now, if (sn)n∈N is another sequence going to +∞, we write:∣∣ρ(sn)− l∣∣ ≤ ∣∣ρ(sn)− ρ(tn)∣∣+ ∣∣ρ(tn)− l∣∣
The second term goes to 0 by definition of l, the first as well by the same inequalities as above.
Thus all subsequences extracted from ρ converge and have the same limit, which proves the
result.
We now state a useful lemma to prove that a function is BV .
Lemma A.2. Let ρ be a function defined on R+ that is bounded from above and such that (ρ′)−
is integrable. Then ρ is BV on R+. (Of course, we have the same result if ρ is bounded from
below and (ρ′)+ is integrable)
Proof. Let q := ρ′.
For t > 0, we want to bound
∫ t
0
∣∣q(s)∣∣ ds independently of t, which would prove that q is an
integrable function. Since
∣∣q∣∣ = q+ + q− = q + 2q−, we can write :∫ t
0
∣∣q(s)∣∣ ds = ∫ t
0
ρ′(s) ds+ 2
∫ t
0
q−(s) ds
= ρ(t)− ρ(0) + 2
∫ t
0
q−(s) ds
with all terms being bounded thanks to the hypotheses.
B Handling positive and negative parts for ODEs
It is often useful to be able to "differentiate" the positive and negative parts of a function that
satisfies an ODE.
Lemma B.1. Let q be a function defined on R+ that satisfies the ODE dqdt = f(t, q) with f a
continuous function on R+ × R.
Then
d(q+)
dt
= f(t, q)1{q>0}.
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Remark B.2. the latter is to be understood in the integral sense, i.e.
∀t > 0, q(t)+ − q(0)+ =
∫ t
0
f(u, q(u))1{q(u)>0} du
Since these are Lipschitz functions, we can also say (thanks to the Rademacher’s theorem) that
the equality d(q+)dt = f(t, q)1{q>0} holds a.e. on R+.
Proof. The idea is that if we denote the positive part function by s, then formally: ddts(q) =
dq
dt s
′(q) with s′(q) = 1{q>0}.
To be more rigorous, we use (sδ)δ>0, a family of smooth functions approximating the positive
part function s. More precisely, we choose the family such that
0 ≤ sδ ≤ 1
sδ = 0 on (−∞ , δ]
sδ = x− δ on [2δ ,+∞)
We also impose that sδ converges uniformly towards s on R, s′δ converges pointwise towards
1{·>0} on R.
We compute
d
dt
sδ(q) =
dq
dt
s′δ(q)
= f(t, q) s′δ(q)
Fixing some t0 > 0 and integrating on [0 , t0], we obtain:
sδ(t0)− sδ(0) =
∫ t0
0
f(u, q(u)) s′δ(q(u)) du (45)
The left-hand side converges to s(t0) − s(0). Also, s′δ(q(u)) converges to 1{q(u)>0} for all
u > 0, and the integrated function is bounded uniformly in δ by the supremum of f on an
appropriate compact set.
Since s is nothing but the positive-part function, we get the expected result.
Remark B.3. With the same arguments, one can prove that:
d(q−)
dt
= −f(t, q)1{q<0}.
C Computations for the explicit solution to the equation on R
Recall that we wish to solve explicitly
∂n
∂t
(t, x) + v
∂n
∂x
(t, x) = β
∂2n
∂x2
(t, x) +R (x, ρ(t))n(t, x).
by assuming that we have a Gaussian initial condition
n(0, x) = n0(x) :=
ρ0√
2piσ0
e
− (x−µ0 )
2
2σ2
0
and looking for a Gaussian solution for all time t > 0:
n(t, x) =
ρ(t)√
2piσ(t)
e
− (x−µ(t))2
2σ(t)2
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Rather than computing the standard deviation σ directly, we define η(t) =
1
2σ(t)2
leading to:
n(t, x) = ρ(t)
√
η(t)
pi
e−η(t)(x−µ(t))
2
, (46)
so that
ln(n) =
1
2
ln
(η
pi
)
+ ln(ρ)− η (x− µ)2
We now compute
1
n
∂n
∂t
=
1
2
η′
η
+
ρ′
ρ
− η′ (x− µ)2 + 2ηµ′ (x− µ) ,
1
n
∂n
∂x
= −2η (x− µ)
1
n
∂2n
∂x2
= −2η + 4η2 (x− µ)2 .
Plugging it into the equation, we are led to:
1
2
η′
η
+
ρ′
ρ
− η′ (x− µ)2 + 2ηµ′ (x− µ)− 2vη (x− µ)
= −2βη + 4βη2 (x− µ)2 + (γ − x2)− dρ
1. Formula for σ
We start by equating the coefficients in front of x2:
η′ + 4βη2 =  (47)
w := η −
√

4β then satisfies the ODE w
′ + 4βw (w + d) = 0 with d :=
√

β .
The equation can be written w
′
w(w+d) = −4β, and since 1X(X+d) = 1d
[
1
X − 1X+d
]
, integration is
possible and yields:
w(t) =
Cde−2at
1− Ce−2at
where C is some constant fixed by the initial conditions and a := 2 (β)
1
2 . Now, solving for σ,
we obtain
σ2(t) = σ2∞
1− Ce−2at
1 + Ce−2at
with
σ2∞ :=
(
β

) 1
2
.
We distinguish now two cases: if the constant C is fixed from the initial condition σ0, and we
do not know its sign a priori.
Suppose first that C is positive so that we can write C := e2α and σ2(t) = σ2∞ tanh (α+ at)
with α := arctanh
(
σ20
σ2∞
)
. This requires σ0 < σ∞.
If C is negative, then we end up with σ2(t) = σ2∞ (tanh (α˜+ at))
−1 with α˜ := arctanh
(
σ2∞
σ20
)
,
which requires σ0 > σ∞.
Reciprocally, we have covered all cases (except σ0 = σ∞ which leads to σ(t) = σ∞ for all t).
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Since we clearly have limt→+∞w(t) = 0, σ(t) converges to σ∞.
2. Formula for µ
We now equate the coefficients in front of x1 to uncover:
2η′µ+ 2ηµ′ − 2vη = −8βη2µ
which can be written
(
η′ + 4βη2
)
µ+ η′µ− vη = 0. Thanks to (47), this leads to the following
ODE:
µ′ + 2σ2µ = v, (48)
an equation providing a formula for µ(t):
µ(t) = e−2
∫ t
0 σ
2(s) ds
[
µ0 + v
∫ t
0
e2
∫ s
0 σ
2(z) dz ds
]
.
This can be made more explicit since the function σ2 has an explicit primitive.2
Let us study the asymptotics for µ. Given the convergence of σ towards σ∞, it is natural to
compare µ to the solution µ˜ of the equation:
µ˜′ + 2σ2∞µ˜ = v
which converges asymptotically to
µ∞ :=
v
a
.
Our aim is to prove that this also holds true for µ.
We first notice that σ is bounded from below by a positive constant. This allows us to write
µ′ + aµ ≤ v for some positive constant a. Integrating this differential inequality shows that µ is
bounded.
We now define g := µ− µ˜ and we are left with proving that g converges to 0 in order to identify
the limit for µ. We compute a differential equation for g:
g′ = 2σ∞µ˜− 2σµ
= −2σ∞g + 2 (σ∞ − σ)µ
Given that µ is bounded, 2 (σ∞ − σ)µ goes to 0 as t goes to +∞, which is enough to prove,
after integration, that g converges to 0 as well.
3. Formula for ρ
We finally equate the constant coefficients:
1
2
η′
η
+
ρ′
ρ
− η′µ2 − 2ηµ′µ+ 2vηµ = −2βη + 4βη2µ2 + γ − dρ
We rewrite this as:
ρ′
ρ
=
[
−1
2
η′
η
− 2βη + γ
]
+ µ
[
η′µ+ 4βη2µ+ 2ηµ− 2vη]− dρ
2For example, in the case where σ0 < σ∞,
µ(t) =
coshα
cosh (α+ at)
[
µ0 − v
a
σ20
σ2∞
]
+
v
a
tanh (α+ at)
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From (47) and (48), the first bracket is equal to − 2η + γ, the second to −µ2. We end up with
an ODE for ρ:
ρ′
ρ
= Q− dρ (49)
where the function Q is given by Q := − 2η + γ − µ2 = γ − 
(
σ2 + µ2
)
.
To solve it, we define h := 1ρ for which we have the ODE:
h′ +Qh = d
Because it satisfies this ODE, h cannot change sign. Consequently, this is also true for ρ which
is positive for all time. ρ is given by:
ρ(t) =
(
e−
∫ t
0 Q(s) ds
[
1
ρ0
+ d
∫ t
0
e
∫ s
0 Q(z) dz ds
])−1
where all integrals could be actually be computed more explicitly.
As for µ, we focus on studying the asymptotical behaviour of ρ. Since Q has a limit given by
Q∞ := γ−
(
σ2∞ + µ2∞
)
, which we assume to be a positive quantity, the same arguments applied
to (48) can be used to prove that h converges to dQ∞ .
Eventually, it ensures that ρ converges to ρ∞ := Q∞d . As a function of the original parameters
only, it is given by:
ρ∞ =
1
d
[
γ −
(
(β)
1
2 +
v2
4β
)]
.
If Q∞ is negative, the arguments above do not apply and the formula for ρ actually shows that
it converges to 0.
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